GMED
GMED
NYSE · Health Care

Globus Medical Inc - A

$81.44
-5.66 (-6.50%)
Financial Highlights (FY 2026)
Revenue
3.06B
Net Income
559.71M
Gross Margin
67.4%
Profit Margin
18.3%
Rev Growth
+42.2%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.4% 67.4% 35.9% 35.9%
Operating Margin 20.3% 18.3% 14.9% 11.7%
Profit Margin 18.3% 17.4% 14.3% 11.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.06B 2.15B 3.46B 3.46B
Gross Profit 2.06B 1.45B 1.24B 1.24B
Operating Income 621.75M 393.60M 516.01M 405.67M
Net Income 559.71M 354.32M 493.69M 399.49M
Gross Margin 67.4% 67.4% 35.9% 35.9%
Operating Margin 20.3% 18.3% 14.9% 11.7%
Profit Margin 18.3% 17.4% 14.3% 11.6%
Rev Growth +42.2% +42.2% +17.0% +21.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.11M 1.11M 625.93M 774.18M
Total Equity 5.56B 5.56B 4.50B 4.57B
D/E Ratio 0.00 0.00 0.14 0.17
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 744.79M 497.68M 684.01M 739.40M
Free Cash Flow — — 424.02M 288.19M